DELMAR PHARMACEUTICALS (DMPI) earnings
Quarterly and annual DMPI reports and results, each read against the price at its own news timestamp. Back to the DMPI overview →
No DMPI earnings events in the measured window.
Nothing matched in the current window — the DMPI overview has every event we measure for this name.
Get an email when DMPI moves on news →Keep exploring
More DMPI: analyst actions → · SEC filings → · DMPI overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CAMBREX (CBM) | 505 | 0.00% | 49% |
| Celyad Oncology SA - American Depositary Shares (CYAD) | 504 | 0.00% | 41% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 504 | -0.09% | 42% |
| CORINDUS VASCULAR ROBOTICS INC (CVRS) | 503 | -0.65% | 37% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.